Immuneering's total assets for Q1 2025 were $50.68M, a decrease of -3.86% from the previous quarter. IMRX total liabilities were $8.84M for the fiscal quarter, a -21.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.